Mircera 75mcg Injection
By Mircera
Rx
1ml Injection in a Vial

Composition
Methoxy polyethylene glycol-epoetin beta(75mcg)

Manufacturer - Roche Products India Pvt Ltd
1503, 15th Floor, 'The Capital', Plot no. C-70, Behind ICICI Bank, BKC, Bandra (E) , Mumbai 400051

Expires on or after
April, 2026

liver
Limited information is currently available regarding the use of Mircera 75mcg Injection in patients with liver disease. It is strongly advised to consult your doctor before using this medication to ensure it is safe and appropriate for your specific condition. Your doctor will be able to provide personalized guidance and assess any potential risks or interactions that may affect your liver health. Taking this precaution is essential for your overall safety and well-being.

kidney
Limited information exists regarding the use of Mircera 75mcg Injection in patients with kidney disease. It is strongly advised to consult with your doctor before using this medication to ensure it is safe for your condition.

alcohol
Consult your doctor when consuming alcohol with Mircera 75mcg Injection.

driving
It is not clear if Mircera 75mcg Injection affects driving ability. Avoid driving if you have symptoms impacting focus or reaction time.

pregnancy
Mircera 75mcg Injection is considered unsafe during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing. Consult your doctor for further guidance.

breastfeeding
During breastfeeding, caution is advised when using Mircera 75mcg Injection. It is recommended to pause breastfeeding until the mother's treatment is finished, and the drug is no longer present in her system.
Habit Forming | No |
Chemical Class | Carboxylic acid and derivatives |
Therapeutic Class | - |
Action Class | - |
₹7927
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025